Curia · 3 days ago
Proposal Analyst I
Wonder how qualified you are to the job?
BiotechnologyHealth Care
Insider Connection @Curia
Responsibilities
Prepare proposals and proposal revisions based on information provided by sales and technical teams.
Evaluate incoming RFPs to ensure clarity of requests.
Lead meetings to define key sponsor drivers, scope of work, and costs for proposals.
Manage proposal process, including acquiring relevant information and internal reviews.
Facilitate approvals from finance, legal, business development, and operations heads.
Prepare quality proposals in a timely manner, considering customer needs.
Manage and prioritize multiple proposals in various stages of completion.
Assure familiarity with all templates and processes required for proposal tasks.
Represent the Proposals Group at handover meetings for newly awarded projects.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
BS in Science or Business, Advanced degree(s) preferred
Must have excellent writing and interpretation skills.
Must have excellent analytical and communication skills.
Must have excellent organizational skills. Ability to track multiple proposals & CET task statuses and proactively seek information from sales and technical staff to ensure timely proposal submission.
The Proposal Analyst position requires proficiency in several software packages: Outlook, Word, Excel and PowerPoint.
Title will be commensurate on education and experience.
Benefits
Generous benefit options (eligible first day of employment)
Paid training, vacation and holidays (vacation accrual begins on first day of employment)
Career advancement opportunities
Education reimbursement
401k program
Learning platform
And more!
Company
Curia
Curia is a biotechnology company that offers discovery biology, synthetic, medicinal chemistry, and small-scale manufacturing services.
Funding
Current Stage
Late StageTotal Funding
unknown2017-08-31Private Equity· Undisclosed
Leadership Team
Recent News
2024-02-23
GlobeNewswire News Room
2024-02-14
Albany Business Review
2024-01-23
Company data provided by crunchbase